SS Innovations International (NASDAQ:SSII) Downgraded by Wall Street Zen to “Strong Sell”

SS Innovations International (NASDAQ:SSII – Get Free Report) was downgraded by analysts at Wall Street Zen from a “sell” rating to a “strong sell” rating in a research report issued to clients and investors on Sunday, Wall Street Zen reports.

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of SS Innovations International in a report on Thursday, October 15th. One analyst has rated the stock with a Sell rating. According to data from MarketBeat, the company has a consensus rating of “Sell” and a consensus price target of $7.00.

Check Out Our Latest Stock Analysis on SSII

SS Innovations International Trading Down 0.8%

SSII opened at $1.27 on Friday. SS Innovations International has a 12 month low of $1.12 and a 12 month high of $6.79. The stock has a market capitalization of $254.48 million, a price-to-earnings ratio of -18.14 and a beta of -1.52. The company has a debt-to-equity ratio of 0.02, a current ratio of 2.10 and a quick ratio of 1.66. The business has a fifty day moving average price of $2.44 and a 200 day moving average price of $3.65.

SS Innovations International (NASDAQ:SSII – Get Free Report) last posted its quarterly earnings results on Monday, November 16th. The company reported ($0.03) earnings per share (EPS) for the quarter. The company had revenue of $6.33 million during the quarter. SS Innovations International had a negative net margin of 31.51% and a negative return on equity of 29.51%.

Insider Buying and Selling

In other news, CEO Srivastava Sudhir sold 33,333 shares of the stock in a transaction dated Friday, September 4th. The shares were sold at an average price of $3.00, for a total transaction of $99,999.00. Following the completion of the sale, the chief executive officer owned 108,520,928 shares in the company, valued at approximately $325,562,784. This represents a 0.03% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Hedge Funds Weigh In On SS Innovations International

A number of large investors have recently modified their holdings of SSII. Goldman Sachs Group Inc. purchased a new position in shares of SS Innovations International in the third quarter valued at $38,000. 71 West Capital Partners purchased a new stake in shares of SS Innovations International in the 3rd quarter worth about $596,000. Inspire Investing LLC grew its stake in SS Innovations International by 19.7% in the 3rd quarter. Inspire Investing LLC now owns 223,053 shares of the company’s stock valued at $665,000 after acquiring an additional 36,756 shares during the last quarter. Finally, Eversept Partners LP grew its stake in SS Innovations International by 46.2% in the 1st quarter. Eversept Partners LP now owns 110,157 shares of the company’s stock valued at $551,000 after acquiring an additional 34,799 shares during the last quarter.

SS Innovations International Company Profile

(Get Free Report)

SS Innovations International is a medical technology company focused on developing and manufacturing surgical robotic systems. Its flagship product, the SSI Mantra, is a multi-arm platform designed to support surgeons during minimally invasive procedures. The company’s offerings include surgical instruments and related technologies, such as its SSI Mudra instruments, as well as training and support services for hospitals and clinicians. The SSI Mantra system is designed with features including a surgeon console and 3D visualization, and the company has also emphasized remote surgery and telementoring capabilities.

Further Reading

Receive News & Ratings for SS Innovations International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SS Innovations International and related companies with MarketBeat.com's FREE daily email newsletter.